| pubmed-article:451506 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:451506 | lifeskim:mentions | umls-concept:C0543467 | lld:lifeskim |
| pubmed-article:451506 | lifeskim:mentions | umls-concept:C0494165 | lld:lifeskim |
| pubmed-article:451506 | lifeskim:mentions | umls-concept:C0392360 | lld:lifeskim |
| pubmed-article:451506 | lifeskim:mentions | umls-concept:C0728940 | lld:lifeskim |
| pubmed-article:451506 | pubmed:issue | 21 | lld:pubmed |
| pubmed-article:451506 | pubmed:dateCreated | 1979-8-29 | lld:pubmed |
| pubmed-article:451506 | pubmed:abstractText | 451 patients undergoing surgery for colorectal cancer showed synchronous hepatic metastases in 24.4% (110 cases). Survival of patients with hepatic metastases appears to depend on both the age of the patient and the site of metastatic deposit. A relatively good prognosis group with median survival of 14 months can be separated from the other patients with only 5 months survival. Survival of patients with hepatic metastases can thus be predicted and long-term survival (5 and 10 years) obtained by surgical excision of these metastases. Postoperative CEA determinations will also increase the rate of early surgery for hepatic metastases. | lld:pubmed |
| pubmed-article:451506 | pubmed:language | fre | lld:pubmed |
| pubmed-article:451506 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:451506 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:451506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:451506 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:451506 | pubmed:month | May | lld:pubmed |
| pubmed-article:451506 | pubmed:issn | 0036-7672 | lld:pubmed |
| pubmed-article:451506 | pubmed:author | pubmed-author:MeyerAA | lld:pubmed |
| pubmed-article:451506 | pubmed:author | pubmed-author:PettavelJJ | lld:pubmed |
| pubmed-article:451506 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:451506 | pubmed:day | 26 | lld:pubmed |
| pubmed-article:451506 | pubmed:volume | 109 | lld:pubmed |
| pubmed-article:451506 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:451506 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:451506 | pubmed:pagination | 794-6 | lld:pubmed |
| pubmed-article:451506 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:451506 | pubmed:meshHeading | pubmed-meshheading:451506-H... | lld:pubmed |
| pubmed-article:451506 | pubmed:meshHeading | pubmed-meshheading:451506-R... | lld:pubmed |
| pubmed-article:451506 | pubmed:meshHeading | pubmed-meshheading:451506-A... | lld:pubmed |
| pubmed-article:451506 | pubmed:meshHeading | pubmed-meshheading:451506-C... | lld:pubmed |
| pubmed-article:451506 | pubmed:meshHeading | pubmed-meshheading:451506-L... | lld:pubmed |
| pubmed-article:451506 | pubmed:meshHeading | pubmed-meshheading:451506-P... | lld:pubmed |
| pubmed-article:451506 | pubmed:meshHeading | pubmed-meshheading:451506-A... | lld:pubmed |
| pubmed-article:451506 | pubmed:meshHeading | pubmed-meshheading:451506-M... | lld:pubmed |
| pubmed-article:451506 | pubmed:meshHeading | pubmed-meshheading:451506-P... | lld:pubmed |
| pubmed-article:451506 | pubmed:meshHeading | pubmed-meshheading:451506-N... | lld:pubmed |
| pubmed-article:451506 | pubmed:meshHeading | pubmed-meshheading:451506-M... | lld:pubmed |
| pubmed-article:451506 | pubmed:meshHeading | pubmed-meshheading:451506-T... | lld:pubmed |
| pubmed-article:451506 | pubmed:meshHeading | pubmed-meshheading:451506-C... | lld:pubmed |
| pubmed-article:451506 | pubmed:year | 1979 | lld:pubmed |
| pubmed-article:451506 | pubmed:articleTitle | [Indication for selective surgical excision of hepatic metastases]. | lld:pubmed |
| pubmed-article:451506 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:451506 | pubmed:publicationType | English Abstract | lld:pubmed |
